Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
Gynecologic Oncology
|
May 1, 1997
Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women
R P Matthews, J Hutchinson-Colas, M Maiman, et al.
Annales De Dermatologie Et De Venereologie
|
May 15, 2012
[Skin toxicity related to Percutalgine(®): analysis of the French pharmacovigilance database]
C Remy, A Barbaud, B Lebrun-Vignes, et al.
Gynecologic Oncology
|
April 1, 1997
Uterine carcinosarcomas: incidence and trends in management and survival
C D Arrastia, R G Fruchter, M Clark, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Nonpeptide glycoprotein IIb/IIIa inhibitors: substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists
N J Liverton, D J Armstrong, D A Claremon, et al.
NMR in Biomedicine
|
June 1, 1989
Limits of tumour treatment follow up by surface coil 31P magnetic resonance spectroscopy. The case of sarcosinamide-CNU treated ependymoblastoma
L Le Moyec, E Le Rumeur, F Darcel, et al.
Biochemistry
|
August 23, 1994
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation
K F Freund, K P Doshi, S L Gaul, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique
|
December 1, 1987
[Multiple correlative studies of stereotaxic biopsies of brain tumors]
A L Benabid, J de Rougemont, M Decorps, et al.
Cardiovascular and Interventional Radiology
|
June 4, 2002
Endovascular treatment of peripheral artery disease with expanded PTFE-covered nitinol stents: interim analysis from a prospective controlled study
S H Duda, M Bosiers, B Pusich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1995
Cardiac electrophysiologic and antiarrhythmic actions of tedisamil
A A Wallace, R F Stupienski, E P Baskin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1984
L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems
M Williams, G E Martin, D C Remy, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
Gynecologic Oncology
|
May 1, 1997
Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women
R P Matthews, J Hutchinson-Colas, M Maiman, et al.
Annales De Dermatologie Et De Venereologie
|
May 15, 2012
[Skin toxicity related to Percutalgine(®): analysis of the French pharmacovigilance database]
C Remy, A Barbaud, B Lebrun-Vignes, et al.
Gynecologic Oncology
|
April 1, 1997
Uterine carcinosarcomas: incidence and trends in management and survival
C D Arrastia, R G Fruchter, M Clark, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Nonpeptide glycoprotein IIb/IIIa inhibitors: substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists
N J Liverton, D J Armstrong, D A Claremon, et al.
NMR in Biomedicine
|
June 1, 1989
Limits of tumour treatment follow up by surface coil 31P magnetic resonance spectroscopy. The case of sarcosinamide-CNU treated ependymoblastoma
L Le Moyec, E Le Rumeur, F Darcel, et al.
Biochemistry
|
August 23, 1994
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation
K F Freund, K P Doshi, S L Gaul, et al.
Revue D'Electroencephalographie Et De Neurophysiologie Clinique
|
December 1, 1987
[Multiple correlative studies of stereotaxic biopsies of brain tumors]
A L Benabid, J de Rougemont, M Decorps, et al.
Cardiovascular and Interventional Radiology
|
June 4, 2002
Endovascular treatment of peripheral artery disease with expanded PTFE-covered nitinol stents: interim analysis from a prospective controlled study
S H Duda, M Bosiers, B Pusich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1995
Cardiac electrophysiologic and antiarrhythmic actions of tedisamil
A A Wallace, R F Stupienski, E P Baskin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1984
L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems
M Williams, G E Martin, D C Remy, et al.
Page
of 13